3-(2-carboxyindol-3-yl)propionic acid has been researched along with mdl29,951 in 3 studies
Studies (3-(2-carboxyindol-3-yl)propionic acid) | Trials (3-(2-carboxyindol-3-yl)propionic acid) | Recent Studies (post-2010) (3-(2-carboxyindol-3-yl)propionic acid) | Studies (mdl29,951) | Trials (mdl29,951) | Recent Studies (post-2010) (mdl29,951) |
---|---|---|---|---|---|
22 | 1 | 11 | 15 | 0 | 9 |
Protein | Taxonomy | 3-(2-carboxyindol-3-yl)propionic acid (IC50) | mdl29,951 (IC50) |
---|---|---|---|
Chain A, Fructose-1,6-bisphosphatase | Sus scrofa (pig) | 2.5 | |
Fructose-1,6-bisphosphatase 1 | Homo sapiens (human) | 2.1667 | |
Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 0.1263 | |
Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.155 | |
Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.155 | |
Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 1.0033 | |
Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.155 | |
Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.155 | |
Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.155 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baron, BM; Harrison, BL; Kehne, JH; McDonald, IA; Nyce, PL; Salituro, FG; Stewart, KT; White, HS | 1 |
Baron, BM; Harrison, BL; McDonald, IA; Nyce, PL; Salituro, FG; Stewart, KT | 1 |
Abdelrahman, A; Akkari, R; Alshaibani, S; Baqi, Y; Ghasimi, S; Kaufmann, O; Köse, M; Kostenis, E; Müller, CE; Namasivayam, V; Pillaiyar, T; Rafehi, M; Ritter, K; Simon, K; Spinrath, A; Zhao, Q | 1 |
3 other study(ies) available for 3-(2-carboxyindol-3-yl)propionic acid and mdl29,951
Article | Year |
---|---|
3-(2-Carboxyindol-3-yl)propionic acid-based antagonists of the N-methyl-D-aspartic acid receptor associated glycine binding site.
Topics: Animals; Binding Sites; Cerebral Cortex; Glycine; Hippocampus; Indoles; Mice; Mice, Inbred DBA; Propionates; Rats; Receptors, N-Methyl-D-Aspartate; Seizures; Structure-Activity Relationship; Strychnine; Substrate Specificity | 1992 |
3-(2-carboxyindol-3-yl)propionic acid derivatives: antagonists of the strychnine-insensitive glycine receptor associated with the N-methyl-D-aspartate receptor complex.
Topics: Animals; Binding Sites; Binding, Competitive; Cerebral Cortex; Glycine; Hippocampus; Indoles; Molecular Structure; N-Methylaspartate; Propionates; Rats; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship; Strychnine | 1990 |
3-(2-Carboxyethyl)indole-2-carboxylic Acid Derivatives: Structural Requirements and Properties of Potent Agonists of the Orphan G Protein-Coupled Receptor GPR17.
Topics: Animals; Antineoplastic Agents; Astrocytoma; Calcium; Humans; Indoles; Models, Molecular; Molecular Structure; Protein Conformation; Rats; Receptors, G-Protein-Coupled; Structure-Activity Relationship; Tumor Cells, Cultured | 2018 |